These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1141 related articles for article (PubMed ID: 20432533)

  • 1. Genetics, pathogenesis and clinical interventions in type 1 diabetes.
    Bluestone JA; Herold K; Eisenbarth G
    Nature; 2010 Apr; 464(7293):1293-300. PubMed ID: 20432533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and primary prevention trials for type 1 diabetes.
    Wu YL; Ding YP; Gao J; Tanaka Y; Zhang W
    Int J Biol Sci; 2013; 9(7):666-79. PubMed ID: 23904791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis, prediction, and prevention of insulin-dependent diabetes mellitus.
    Muir A; Schatz DA; Maclaren NK
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):199-219. PubMed ID: 1612064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New and future immunomodulatory therapy in type 1 diabetes.
    Tooley JE; Waldron-Lynch F; Herold KC
    Trends Mol Med; 2012 Mar; 18(3):173-81. PubMed ID: 22342807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy in autoimmune type 1 diabetes.
    Weigmann B; Franke RK; Daniel C
    Rev Diabet Stud; 2012; 9(2-3):68-81. PubMed ID: 23403703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes research: are we getting anywhere?
    Zinman B
    CMAJ; 1996 Nov; 155(9):1271-4. PubMed ID: 8911293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of animal models of type 1 diabetes, and strategies to enhance their utility in translational research.
    Graham ML; Schuurman HJ
    Eur J Pharmacol; 2015 Jul; 759():221-30. PubMed ID: 25814249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Frontiers in the Treatment of Type 1 Diabetes.
    Warshauer JT; Bluestone JA; Anderson MS
    Cell Metab; 2020 Jan; 31(1):46-61. PubMed ID: 31839487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update in type 1 diabetes.
    Eisenbarth GS
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2403-7. PubMed ID: 17616634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Type 1 Diabetes PhysioLab Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouse.
    Shoda L; Kreuwel H; Gadkar K; Zheng Y; Whiting C; Atkinson M; Bluestone J; Mathis D; Young D; Ramanujan S
    Clin Exp Immunol; 2010 Aug; 161(2):250-67. PubMed ID: 20491795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention strategies for type 1 diabetes mellitus: current status and future directions.
    Winter WE; Schatz D
    BioDrugs; 2003; 17(1):39-64. PubMed ID: 12534319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing type 1 diabetes mellitus: the promise of gene therapy.
    Efrat S
    Am J Pharmacogenomics; 2002; 2(2):129-34. PubMed ID: 12083947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 diabetes: new perspectives on disease pathogenesis and treatment.
    Atkinson MA; Eisenbarth GS
    Lancet; 2001 Jul; 358(9277):221-9. PubMed ID: 11476858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the pathogenesis of type 1 diabetes: a hint for novel immunospecific therapies.
    Casares S; Brumeanu TD
    Curr Mol Med; 2001 Jul; 1(3):357-78. PubMed ID: 11899083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology of type 1 diabetes. Intervention and prevention strategies.
    Bertera S; Alexander A; Giannoukakis N; Robbins PD; Trucco M
    Endocrinol Metab Clin North Am; 1999 Dec; 28(4):841-64, x. PubMed ID: 10609123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to prevent type 1 diabetes.
    Thrower SL; Bingley PJ
    Diabetes Obes Metab; 2009 Oct; 11(10):931-8. PubMed ID: 19476469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Intervention and Preservation of Pancreatic Beta Cell Function in Type 1 Diabetes.
    Simmons KM; Gottlieb PA; Michels AW
    Curr Diab Rep; 2016 Oct; 16(10):97. PubMed ID: 27558810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics for targeting disease prevention: diabetes.
    Newell AM
    Prim Care; 2004 Sep; 31(3):743-66, xii. PubMed ID: 15331257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of immune-mediated (type 1) diabetes mellitus: potential for immunotherapy.
    Abel M; Krokowski M
    BioDrugs; 2001; 15(5):291-301. PubMed ID: 11437693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of type 1 diabetes from laboratory to public health.
    Flanders G; Graves P; Rewers M
    Autoimmunity; 1999; 29(3):235-46. PubMed ID: 10433102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.